Filing Details
- Accession Number:
- 0001735276-18-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-04 16:25:45
- Reporting Period:
- 2018-05-31
- Accepted Time:
- 2018-06-04 16:25:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219015 | K John Clarke | 300 Third Street Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-31 | 15,000 | $27.28 | 23,891 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-31 | 2,758 | $99.38 | 21,133 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-31 | 10,042 | $100.33 | 11,091 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-31 | 2,100 | $101.37 | 8,991 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-31 | 100 | $101.97 | 8,891 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-05-31 | 15,000 | $0.00 | 15,000 | $27.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-06-03 | 2018-06-02 | No | 4 | M | Direct |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 20, 2018.
- Sales prices ranged from $98.89 to $99.75.
- Sales prices ranged from $99.92 to $100.90.
- Sales prices ranged from $100.97 to $101.88.
Billionaire Hedge Funds
